Brighton Jones’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Brighton Jones's CRL Position: Q3 2026 in Review
Brighton Jones increased its Charles River Laboratories (CRL) stake by 1.1% in Q3 2026, buying an estimated $2.64K and bringing the position to 945 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.
Brighton Jones first reported a position in CRL in Q2 2021 and has held it in 3 quarters since. The position peaked at $287K in Q2 2021. 533 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Brighton Jones held 945 shares of Charles River Laboratories worth $279K as of Q3 2026.
- Brighton Jones bought 10 Charles River Laboratories shares in Q3 2026, an estimated $2.64K.
- Charles River Laboratories made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1099 holding.
- Brighton Jones first reported a position in Charles River Laboratories in Q2 2021 and has held it in 3 quarters since.
- Brighton Jones's Charles River Laboratories position peaked at $287K in Q2 2021.
- 533 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.